MC2 Therapeutics and Huadong to commercialize psoriasis cream in Greater China
Huadong has been granted exclusive rights in Greater China to develop and commercialize MC2’s drug, Wynzora Cream, for the treatment of plaque psoriasis.
Archives for September 5, 2023
Intellegens and CPI awarded £1.6m Innovate UK grant
Intellegens, a company applying machine learning (ML) to accelerate innovation in R&D, has secured a £1.6m grant from Innovate UK, to apply ML in the emerging field of oligonucleotide therapies.
Q&A: The potential of immuno-oncology - a view from the R&D department
Cancer immunotherapy, more commonly known as immuno-oncology, continues to gather momentum. As a rapidly evolving field, ongoing research and advancements are coming together to expand the number of available treatments, many of which are showing...